Skip to main content
Clinical Trials/NCT02115802
NCT02115802
Unknown
Not Applicable

Local Field Potential Correlates of Motor Behavior and Pathological Signs in Movement Disorders for Development of Closed Loop Stimulation Systems

Colorado Neurological Institute1 site in 1 country10 target enrollmentMay 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Parkinson's Disease
Sponsor
Colorado Neurological Institute
Enrollment
10
Locations
1
Primary Endpoint
Specific features of local field potentials recorded from the deep brain nuclei during different natural behaviors, such as movement, walking, or speech.
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to record electrical brain activity during DBS surgery and after DBS surgery using the Medtronic Activa PC+S deep brain stimulation (DBS) system, a modified DBS pulse generator. The goal of the study is to investigate if the electrical brain activity can help customize DBS therapy.

Detailed Description

The Activa PC+S system will be implanted and programmed under the same clinical procedures and standard of care as the Activa PC system. After implantation and standard clinical programming, participants in our research study will be asked to return for additional research visits where the recording sub-circuit of the device will be activated and local field potentials (LFP) will be recorded in the device and transmitted through telemetry to a base station for storage and future analysis. The sensing, or recording, sub-circuit will be disabled, non-invasively, at the end of each research visit to minimize impact to battery life of the device.

Registry
clinicaltrials.gov
Start Date
May 2014
End Date
December 2017
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Colorado Neurological Institute
Responsible Party
Principal Investigator
Principal Investigator

Adam O Hebb

Principal Investigator

Colorado Neurological Institute

Eligibility Criteria

Inclusion Criteria

  • Potential participants must be undergoing DBS lead placement for Parkinson's Disease that requires them to be awake during microelectrode recording.
  • Potential participants have been treated with levodopa/carbidopa, and with a dopamine agonist, at the maximal tolerated doses as determined by a movement disorders neurologist.
  • Potential participants must have a Hoehn and Yahr stage \>= 2 in the medications OFF state.
  • Potential participants must have documented improvement in motor signs on versus off dopaminergic medication, with a change in the Unified Parkinson's Disease Rating Scale motor (UPDRS III) score of \>= 30% off to on medication. Patients with tremor predominant form of PD, quantified as a UPDRS tremor score in any one limb greater than or equal to 3 and UPDRS sum of axial score (speech, posture, gait, balance) less than or equal to 5, who do not reach the 30% threshold, may be included.
  • Potential participants must have evidence of complications of medication, e.g., wearing off signs, fluctuating responses and/or dyskinesias, and/or medication refractory tremor, and/or impairment in the quality of life on or off medication.
  • Potential participants must have the ability to understand instructions in English.
  • Potential participants are males or females between the ages of 21 and 75.

Exclusion Criteria

  • Individuals who are pregnant, breastfeeding, or are capable of becoming pregnant and not using an acceptable method of birth control. Acceptable methods of birth control include hormonal contraceptives, intrauterine device, abstinence or spermicide and barrier.
  • Individuals who have magnetic resonance imaging (MRI) scans demonstrating cortical atrophy out of proportion to age.
  • Individuals who have MRI scans showing focal brain lesions that could indicate a nonidiopathic movement disorder.
  • Individuals who have major comorbidity increasing the risk of surgery such as prior stroke, severe hypertension, severe diabetes, or need for chronic anticoagulation other than aspirin.
  • Individuals who have had any prior intracranial surgery.
  • Individuals who have clinically active depression defined according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria and scored on a validated depression assessment scale.
  • Individuals who have significant cognitive impairment and/or dementia as determined by a standardized neuropsychological battery.
  • Individuals who have a history of seizures.
  • Individuals who are immunocompromised.
  • Individuals who have an active infection.

Outcomes

Primary Outcomes

Specific features of local field potentials recorded from the deep brain nuclei during different natural behaviors, such as movement, walking, or speech.

Time Frame: 3 years

The broadband time domain neural signal across all bipolar pairs will be recorded in series while subjects perform structured behavioral tasks.

Study Sites (1)

Loading locations...

Similar Trials